All Americans aged 12 and older are now eligible to be vaccinated. Those 16 or older can receive all three vaccines that have been authorized for emergency use. Children between the ages of 12-15 are also eligible for the Pfizer vaccine. Vaccine makers are currently conducting trials for younger children.

While individuals who come to the emergency department or an urgent care center may be vaccinated (once it’s ready and available for their respective group), it may be easier to get vaccinated by your primary care provider, pharmacist, or local health department, particularly if they need to follow up with you about getting the second dose of the Pfizer or Moderna vaccines.

Learn more at vaccines.gov

All of the available vaccines effectively protect against severe illness from COVID-19. The ability to choose which you receive depends on a number of factors, including the supply in your area at the time you’re vaccinated and whether certain vaccines are found to be more effective in certain populations, such as older adults. However, if you receive a Pfizer or Moderna vaccine, you need to get the same shot each time.

Yes. Pregnant women are more likely to get severely ill and require hospitalization with COVID-19 compared to those who are not pregnant. COVID-19 also may place the pregnancy at risk, including pre-term birth. It’s important to discuss your specific situation with your health care professional.

Yes, the vaccine is free, although you may want to check with your health insurer about whether they will cover the cost to administer the vaccine.

As with all vaccines, clinical trials rigorously evaluated the COVID-19 vaccine to generate scientific data and other information for the U.S. Food and Drug Administration (FDA) to determine their safety and effectiveness. Both Moderna and Pfizer's vaccines prevented more than 90 percent of COVID-19 cases, and even those that did contract the virus only had mild symptoms. The J&J/Janssen vaccine prevented 66.3 percent of COVID-19, and similarly protected against severe symptoms.

While "Project Warp Speed" removed the barriers and time associated with reporting and other logistical barriers, the companies still had to follow the FDA’s usual vaccine approval process to ensure they provide the appropriate protections and meet all required safety measures. Each company’s application to the FDA included two months of follow-up safety data from Phase 3 of clinical trials conducted by universities and other independent bodies. In that phase, tens of thousands of volunteers got a vaccine and waited to see if they became infected, compared with others who received a placebo. No serious safety concerns were reported in any of the vaccines.

Even after a vaccine is authorized or approved for use, there are vaccine safety monitoring systems that watch for adverse events or possible side effects. This continued monitoring can pick up on possible side effects that may not have been seen in clinical trials. If an unexpected adverse event is detected, experts quickly study it further to assess whether it is a true safety concern. Experts then decide whether changes are needed in the vaccine recommendations.

One of these systems is the CDC’s voluntary V-SAFE program. V-SAFE will use text messaging and web surveys for the CDC to check in with those who received the COVID-19 vaccine to see if health problems arose following vaccination. The system also will follow up via phone with anyone who reports medically significant side effects.

Some participants in vaccine trials experienced typical mild viral symptoms including fever, muscle aches, bad headaches, and fatigue after receiving the shots, but the side effects generally did not last more than a day. You may have stronger symptoms 24 hours after the second dose. Preliminary data suggests that, compared with most flu vaccines, the COVID-19 shots have a somewhat higher rate of such reactions, which are almost always normal signs that the body’s immune response is kicking in.

A small number of those first vaccinated had an allergic reaction following the injection. Therefore, we recommend that those with a history of significant allergic reactions or anaphylaxis check with their physicians before receiving the vaccine.

Researchers and government officials will continue to monitor those who have received the vaccine to study potential side-effects and determine if we need to adjust our current vaccine recommendations. Despite the chance of possible side effects, the vaccine is a safe and critically necessary step in ensuring we, as a society, can help to reduce the spread of the virus, end of this pandemic, and return to our usual way of life.

Yes, you should still plan on getting the vaccine, but you should wait until those with a greater health risk receive theirs first. Although people who have contracted the virus do have immunity—called natural immunity—it is unclear how long it lasts. Some early evidence seems to suggest that natural immunity may not last very long. Regarding vaccination, we won’t know how long immunity lasts until we have more data on how well the vaccine works.

The Pfizer, Moderna, and J&J/Janssen vaccines are very effective at preventing serious illness from the virus, and preliminary data has shown that fully-vaccinated individuals are unlikely to transmit the virus to others. However, the CDC currently recommends that vaccinated individuals continue to wear a mask indoors in public if you live with, or are in close contact with, someone who is immunocompromised or unvaccinated (such as children under the age of 12).

Until you are fully-vaccinated, you should still plan to wear a protective mask when in public and maintain social distance from unvaccinated people. It takes several weeks for your body to build an adequate protective response. Two weeks after your second dose, you will only need to wear a mask or maintain social distance in circumstances recommended by the CDC, such as in areas with significant community spread.

Experts do not know what percentage of people would need to get vaccinated to achieve herd immunity to COVID-19.

“Herd immunity” is a term used to describe when enough people have protection—either from previous infection or vaccination—that it is unlikely a virus or bacteria can spread and cause disease. As a result, everyone within the community is protected even if some people don’t have any protection themselves. The percentage of people who need to have protection in order to achieve herd immunity varies by disease.

You can visit the CDC’s COVID-19 vaccine page or visit the website of your state’s department of health if you have additional questions.